NINDS Neuroscience Funding Announcements

Validation of Novel Therapeutic Targets for Huntington’s Disease (R01)

Funding Contact(s): Margaret Sutherland, Ph.D.
Funding Categories: Neurodegeneration

Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS) invites research project grant (R01) applications aimed at validating novel molecular targets for disease-modifying therapeutic intervention in Huntington’s disease. This FOA is for support of new projects, and not the continuation of projects that have already been initiated with NIH funding.

Grant Mechanism: R01
NIH Guide: PAS-10-183
Release Date: 2010-04-30
Expiration Date: 2013-05-08